Table 3 Clinical outcomes of endovascular treatment
Before matching | Matched population | |||||
|---|---|---|---|---|---|---|
Repeat DCB | De novo DCB | p-value | Repeat DCB | De novo DCB | p-value | |
n = 64 | n = 673 | n = 49 | n = 49 | |||
Primary patency | 56.9% | 82.8% | < 0.001 | 50.1% | 77.4% | 0.029 |
Restenosis (Focal/Tandem/Diffuse) | 69% (32%/6%/31%) | 64% (41%/6%/17%) | 0.514 | 64% (21%/7%/36%) | 57% (57%/0%/0%) | 0.557 |
Reocclusion (Focal/Tandem/Diffuse) | 31% (6%/0%25%) | 36% (10%/0%/26%) | 0.514 | 36% (7%/0%/29%) | 43% (0%/0%/43%) | 0.557 |
Freedom from TLR | 59.3% | 86.0% | < 0.001 | 54.9% | 83.6% | 0.044 |
Major adverse limb event | 58.0% | 73.9% | 0.029 | 48.3% | 73.4% | 0.055 |
Survival rate | 86.5% | 84.7% | 0.943 | 84.6% | 80.5% | 0.848 |
Major amputation | 4.6% | 2.7% | 0.942 | 6.4% | 3.4% | 0.543 |
Early restenosis | 8.8% | 1.9% | 0.009 | 10.7% | 5.9% | 0.455 |
Dissection type A/B/C/D/E | 7%/41%/28%/21%/2% | 14%/41%/24%/20%/1% | 0.268 | 5%/44%/29%/22%/0% | 15%/38%/31%/10%/5% | 0.193 |